Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea · Delayed Price · Currency is KRW 2,430.00
-30.00 (-1.22%)
At close: Sep 3, 2026
Sewoon Medical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 66,529 | 63,657 | 60,151 | 68,247 | 60,116 | 62,579 |
Revenue Growth | 10.39% | 5.83% | -11.86% | 13.53% | -3.94% | -1.80% |
Gross Profit Gross Profit Growth | 25,237 | 23,545 | 22,188 | 27,557 | 22,220 | 25,057 |
Operating Income Operating Income Growth | 14,332 | 12,701 | 11,377 | 16,920 | 12,187 | 15,386 |
Net Income Net Income Growth | 13,897 | 11,912 | 12,163 | 14,957 | 10,406 | 12,282 |
Earnings Per Share EPS Growth | 329.26 | 278.50 | 281.00 | 345.50 | 240.38 | 283.70 |
EPS Growth | 40.13% | -0.89% | -18.67% | 43.73% | -15.27% | 17.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 99,640 | 97,024 | 86,098 | 75,710 | 57,003 | 51,852 |
Total Debt Total Debt Growth | 1,126 | 763.8 | 1,053 | 781.66 | 1,043 | 810.09 |
Net Cash (Debt) Net Cash Growth | 98,514 | 96,260 | 85,045 | 74,929 | 55,961 | 51,042 |
Net Cash Growth | 11.21% | 13.19% | 13.50% | 33.89% | 9.64% | 51.57% |
Net Cash Per Share Net Cash Per Share Growth | 2333.99 | 2250.53 | 1964.85 | 1730.81 | 1292.66 | 1179.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 15,925 | 17,773 | 13,186 | 23,076 | 9,279 | 21,469 |
Capital Expenditures CapEx Growth | -1,630 | -1,691 | -1,435 | -1,949 | -2,151 | -2,224 |
Free Cash Flow Free Cash Flow Growth | 14,295 | 16,083 | 11,750 | 21,127 | 7,128 | 19,244 |
Free Cash Flow Growth | 11.71% | 36.87% | -44.38% | 196.41% | -62.96% | 13.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.93% | 36.99% | 36.89% | 40.38% | 36.96% | 40.04% |
Operating Margin | 21.54% | 19.95% | 18.91% | 24.79% | 20.27% | 24.59% |
Pretax Margin | 27.01% | 23.41% | 25.97% | 28.28% | 22.67% | 26.57% |
Profit Margin | 20.89% | 18.71% | 20.22% | 21.92% | 17.31% | 19.63% |
FCF Margin | 21.49% | 25.26% | 19.54% | 30.96% | 11.86% | 30.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 70.000 | - | - | 70.000 | 60.000 | 50.000 |
Dividend Per Share Growth | 16.67% | - | - | 16.67% | 20.00% | 0% |
Dividend Yield | 2.88% | - | - | 2.58% | 2.22% | 1.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.50 | 8.85 | 8.77 | 8.28 | 12.15 | 14.65 |
Forward PE | - | 13.09 | 13.09 | 13.09 | 13.09 | 13.09 |
P/FCF Ratio | 7.29 | 6.55 | 9.08 | 5.86 | 17.74 | 9.35 |
PS Ratio | 1.57 | 1.66 | 1.77 | 1.81 | 2.10 | 2.87 |